47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,8 | -4,8 | 1 | 119,8 |
EBITDA | 0 | -0 | -0 | 98,2 |
Short time liabilities | 0 | 68,8 | 0,5 | -99,3 |
Equity capital | -1,9 | -5,8 | 56,6 | 1071,3 |
Operating profit (EBIT) | 0 | -0 | -0 | 98,2 |
Assets | 57,5 | 63 | 57,1 | -9,3 |
Net profit (loss) | -1 | -3,9 | -0,8 | 80,2 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0,1 | 737,5 |
Liabilities and provisions for liabilities | 59,5 | 68,8 | 0,5 | -99,3 |
Working assets | 0 | 0,8 | 0,4 | -50,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 52,9 | 67 | -1,4 | -68,4 |
Equity capital to total assets | -3,3 | -9,3 | 99,2 | 108,5 |
Gross profit margin | -19 075,7 | -50 242,4 | 1190,2 | 51 432,6 |
EBITDA Margin | 1,2 | -515,7 | -1,1 | 514,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 2 615 187 | 2152 | -2 613 035 |
Current financial liquidity indicator | 23.59014892578125 | 0.012263050302863121 | 0.8815921545028687 | 0,9 |
Net dept to EBITDA | 502851.8125 | -1389.27294921875 | -509.3286437988281 | 880 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane